Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ELECTRO OPTICAL SCIENCES INC /NY | 67,570 | reported | 05 Feb 2014 | tx 2+467,570 |
| Certara, Inc. | 45,672 | reported | 14 May 2026 | tx 12+91,344−45,672 |
| EPOCRATES INC | 35,024 | reported | 24 Mar 2011 | tx 1+35,024 |
| Targanta Therapeutics Corp. | 25,000 | reported | 25 Aug 2008 | tx 1+25,000 |
| Catalent, Inc. | 23,873 | reported | 27 Oct 2023 | tx 7+22,680 |
| PDS Biotechnology Corp | 10,000 | reported | 15 Mar 2019 | tx 5+70,000−10,000 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 7,242 | reported | 28 May 2026 | tx 30+229,350−113,117 |
| Tarsus Pharmaceuticals, Inc. | 5,350 | reported | 24 Jun 2024 | tx 11+51,050−5,350 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 7,242 | 0.00 USD | deriv |
| 14 May 2026 | EXERCISE | Certara, Inc. | 15,757 | 0.00 USD | |
| 14 May 2026 | EXERCISE | Certara, Inc. | 15,757 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | — | |
| 05 Jun 2025 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 14,492 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | 0.00 USD | deriv |
| 21 May 2025 | EXERCISE | Certara, Inc. | 11,928 | 0.00 USD | |
| 21 May 2025 | EXERCISE | Certara, Inc. | 11,928 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | Certara, Inc. | 15,757 | 0.00 USD | deriv |
| 24 Jun 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 3,350 | — | |
| 24 Jun 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 3,350 | 0.00 USD | deriv |
| 15 Jun 2024 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 21,108 | — | |
| 15 Jun 2024 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 21,108 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 3,350 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | 0.00 USD | deriv |
| 21 May 2024 | EXERCISE | Certara, Inc. | 8,663 | 0.00 USD | |
| 21 May 2024 | GRANT_AWARD | Certara, Inc. | 11,928 | 0.00 USD | deriv |
| 21 May 2024 | EXERCISE | Certara, Inc. | 8,663 | 0.00 USD | deriv |
| 27 Oct 2023 | GRANT_AWARD | Catalent, Inc. | 6,993 | 0.00 USD | |
| 04 Aug 2023 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 15,810 | — | |
| 04 Aug 2023 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 15,810 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 3,350 | 0.00 USD | deriv |
| 16 Jun 2023 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 2,000 | — |